Results 91 to 100 of about 29,800 (242)

Acneiform type of mogamulizumab‐associated rash

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Inga Hansen‐Abeck   +5 more
wiley   +1 more source

Ophthalmological perspectives of toxic epidermal necrolysis

open access: yesArchives of Medicine and Health Sciences, 2019
Toxic epidermal necrolysis (TEN) is as rare as two cases per million per year, but the ocular manifestations and sequelae are very severe. We present a case series of seven patients admitted to the intensive care unit in a tertiary hospital with a ...
Gayatree Mohanty   +3 more
doaj   +1 more source

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China

open access: yesJournal of Immunological Research, 2018
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening disease. However, there are only few epidemiologic studies of SJS/TEN from China.
Shang-Chen Yang   +6 more
semanticscholar   +1 more source

Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea

open access: yesPLoS ONE, 2016
Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases; however, it is hard to estimate their incidence due to the rarity of these diseases.
Min-Suk Yang   +9 more
semanticscholar   +1 more source

The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients’ lives: a Critically Appraised Topic*

open access: yesBritish Journal of Dermatology, 2019
A 65‐year‐old man presented with a 12‐h history of deteriorating rash. Two weeks previously he had completed a course of neoadjuvant chemotherapy for ductal carcinoma of the breast.
P. O’Reilly   +13 more
semanticscholar   +1 more source

Deep cutaneous Trichosporon asahii infection in a patient recovering from toxic epidermal necrolysis

open access: yesMedical Mycology Case Reports, 2019
Patients with toxic epidermal necrolysis, a condition that causes full thickness epidermal necrosis that affects over 30% of the skin surface and mucosal membranes, often develop comorbid infections throughout the recovery of the disease [1].
John L. Kiley   +4 more
doaj  

Clinical Case of Toxic Epidermal Necrolysis

open access: yesActa Medica Bulgarica, 2017
Toxic epidermal necrolysis or Lyell’s syndrome is a severe life-threatening adverse drug reaction with a high mortality rate. The drugs most commonly involved are: antibiotics; anticonvulsants; antiretroviral drugs; nonsteroidal anti-inflammatory drugs ...
Radenkova-Saeva J., Naydenov H.
doaj   +1 more source

Home - About - Disclaimer - Privacy